Summary: Nathan Cheng (@realNathanCheng), program director for On Deck Longevity, joins Erik on this episode to discuss:<br><br>- The key breakthroughs in aging research in the past.<br><br>- Why we're still waiting for the first success story in humans, and why he predicts the first drug will be approved in the next ten years.<br><br>- Why the space has plenty of capital but not enough founders.<br><br>- The challenges and roadblocks in the space.<br><br>- Common misconceptions about longevity.<br><br>- Who should think about applying to the program.<br><br>Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. <br><br>Check us out on the web at <a href="http://www.villageglobal.vc" rel="noopener">www.villageglobal.vc</a> or get in touch with us on Twitter @villageglobal.<br><br>Want to get updates from us? Subscribe to get a peek inside the Village. We’ll send you reading recommendations, exclusive event invites, and commentary on the latest happenings in Silicon Valley. <a href="http://www.villageglobal.vc/signup" rel="noopener">www.villageglobal.vc/signup</a>
